6th Edition of Euro-Global Conference on Biotechnology and Bioengineering
September 28-30 | Hybrid Event
Delivery of Genes, Drugs, or Cells
Gene delivery systems are vital for treating human genetic conditions with gene therapy. Gene therapy is a one-of-a-kind method of curing any ailment by using an adaptable gene. Gene therapy is a promising treatment option for a variety of diseases, including hereditary disorders, viral infections, and cancer. The effective effects of gene delivery systems are dependent on the ability to target gene delivery systems in a variety of ways. For the practical use of gene therapy, certain viable gene delivery techniques have recently been reported. Various disorders induced by environmental chemical poisons, bacterial infections, viral invasions, malignant tumours, and endogenous genetic abnormalities are treated by drug and gene delivery systems. Although the majority of contemporary gene delivery technologies are based on mammalian viruses or synthetic materials meant to mimic virus gene delivery features, different biological systems can still be used as gene delivery vectors.
Murray Moo Young
University of Waterloo, Canada
Limongi Tania
University of Turin, Italy
Luis Jesus Villarreal Gomez
Universidad Autonoma de Baja California, MexicoSubmit your abstract Today
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Improving health in over 40,000 patients: The impact of nanomedicine fighting antibiotic resistant infections
Thomas J Webster, Brown University, United States
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Comparative study of endo-?-1,4-mannanases from novel bacterial strains for the production of galactomanno-oligosaccharides
Shruti Saini, National Agri-food and Bio-manufacturing Institute, India
Title : Engineering Sf9 host cells with AcMNPV genes to control baculovirus infection dynamics and heterologous gene expression
Tamer Z Salem, Zewail City of Science and Technology, Egypt